153 related articles for article (PubMed ID: 30040869)
21. Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.
Pinheiro D; Chang YM; Bryant H; Szladovits B; Dalessandri T; Davison LJ; Yallop E; Mills E; Leo C; Lara A; Stell A; Polton G; Garden OA
PLoS One; 2014; 9(8):e105027. PubMed ID: 25119018
[TBL] [Abstract][Full Text] [Related]
22. Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.
Hayano A; Komohara Y; Takashima Y; Takeya H; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Yamanaka R
Anticancer Res; 2017 Oct; 37(10):5655-5666. PubMed ID: 28982883
[TBL] [Abstract][Full Text] [Related]
23. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
24. Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma.
Rao S; Lana S; Eickhoff J; Marcus E; Avery PR; Morley PS; Avery AC
J Vet Intern Med; 2011; 25(5):1097-105. PubMed ID: 21781170
[TBL] [Abstract][Full Text] [Related]
25. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid-peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma.
Statham-Ringen KA; Selting KA; Lattimer JC; Henry CJ; Green JA; Bryan JN; Jia F; Lewis MR
Am J Vet Res; 2012 May; 73(5):681-8. PubMed ID: 22533400
[TBL] [Abstract][Full Text] [Related]
27. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the prognostic significance of BCL6 gene expression in canine high-grade B-cell lymphoma.
Sato M; Kanemoto H; Kagawa Y; Kobayashi T; Goto-Koshino Y; Mochizuki H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2012 Jan; 191(1):108-14. PubMed ID: 21277811
[TBL] [Abstract][Full Text] [Related]
29. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
Kassardjian A; Shintaku PI; Moatamed NA
PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of CD25-positive cells in relation to the subtypes and prognoses in various lymphoid tumours in dogs.
Mizutani N; Goto-Koshino Y; Tsuboi M; Kagawa Y; Ohno K; Uchida K; Tsujimoto H
Vet Immunol Immunopathol; 2016 May; 173():39-43. PubMed ID: 27090625
[TBL] [Abstract][Full Text] [Related]
31. Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma.
Mitchell L; Dow SW; Slansky JE; Biller BJ
Vet Immunol Immunopathol; 2012 Feb; 145(3-4):597-603. PubMed ID: 22293625
[TBL] [Abstract][Full Text] [Related]
32. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4-CD8- by flow cytometry.
Harris LJ; Rout ED; Labadie JD; Avery PR; Fernandez M; Yoshimoto J; Avery AC
Vet Comp Oncol; 2020 Sep; 18(3):416-427. PubMed ID: 31951040
[TBL] [Abstract][Full Text] [Related]
34. Immune regulation of canine tumour and macrophage PD-L1 expression.
Hartley G; Faulhaber E; Caldwell A; Coy J; Kurihara J; Guth A; Regan D; Dow S
Vet Comp Oncol; 2017 Jun; 15(2):534-549. PubMed ID: 26842912
[TBL] [Abstract][Full Text] [Related]
35. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry.
Gaines PJ; Powell TD; Walmsley SJ; Estredge KL; Wisnewski N; Stinchcomb DT; Withrow SJ; Lana SE
Am J Vet Res; 2007 Apr; 68(4):405-10. PubMed ID: 17397297
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma.
Dutta SK; Novilla MN; Bumgardner MK; Ingling A
Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738
[TBL] [Abstract][Full Text] [Related]
37. Application of Immunophenotyping and Heteroduplex Polymerase Chain Reaction (hPARR) for Diagnosis of Canine Lymphomas.
Sirivisoot S; Techangamsuwan S; Tangkawattana S; Rungsipipat A
Asian Pac J Cancer Prev; 2016; 17(6):2909-16. PubMed ID: 27356711
[TBL] [Abstract][Full Text] [Related]
38. Hematological ratios and indices in canine large B-cell lymphoma.
Gavazza A; Cremonini V; Miglio A; Starita C; Rossi G; Antognoni MT
Open Vet J; 2024 Apr; 14(4):980-989. PubMed ID: 38808287
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
